Molecular biomarkers for predicting complete response to preoperative chemoradiation in people with locally advanced rectal cancer

This is a protocol for a Cochrane Review (prognosis). The objectives are as follows: Primary objectives To identify and estimate the prognostic value of molecular biomarkers as predictors of pathological complete response to neoadjuvant chemoradiotherapy in people with locally advanced rectal cancer. summarises the review question in population, index prognostic factor, comparator prognostic factor(s), outcome, timing, and setting (PICOTS) format. [Table: see text] [Figure: see text] Secondary objectives To explore the following biomarker measurement, treatment, and study design factors as possible sources of heterogeneity in the association between the prognostic factor and pathological response: type of assay/measurement method, biomarker positivity criteria or cut-off point, chemotherapy regimen, and radiotherapy regimen.

Authors

Institutions

Publication Details

Journal
Cochrane Database of Systematic Reviews
Published
2024-11-29
DOI
https://doi.org/10.1002/14651858.cd014718
Citations
1
Primary Topic
Colorectal Cancer Surgical Treatments
Type
article
Field-Weighted Citation Impact
0.28
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular biomarkers for predicting complete response to preoperative chemoradiation in people with locally advanced rectal cancer

Maija R.J. Kohonen‐Corish, Sarah J. Lord, Catherine E Caldon, Matthew J. Morgan et al.
1 citations
Cochrane Database of Systematic Reviews
Colorectal Cancer Surgical Treatments
0.28
article

Molecular biomarkers for predicting complete response to preoperative chemoradiation in people with locally advanced rectal cancer

Maija R.J. Kohonen‐Corish, Sarah J. Lord, Catherine E Caldon, Matthew J. Morgan, Penelope A De Lacavalerie
article en
1 citations

Abstract

This is a protocol for a Cochrane Review (prognosis). The objectives are as follows: Primary objectives To identify and estimate the prognostic value of molecular biomarkers as predictors of pathological complete response to neoadjuvant chemoradiotherapy in people with locally advanced rectal cancer. summarises the review question in population, index prognostic factor, comparator prognostic factor(s), outcome, timing, and setting (PICOTS) format. [Table: see text] [Figure: see text] Secondary objectives To explore the following biomarker measurement, treatment, and study design factors as possible sources of heterogeneity in the association between the prognostic factor and pathological response: type of assay/measurement method, biomarker positivity criteria or cut-off point, chemotherapy regimen, and radiotherapy regimen.

Cochrane Database of Systematic ReviewsVol. 2024(11)
The University of Sydney (AU), Garvan Institute of Medical Research (AU), Bankstown Lidcombe Hospital (AU), Woolcock Institute of Medical Research (AU), UNSW Sydney (AU), Prince of Wales Hospital (AU), St Vincent's Clinic (AU), National Health and Medical Research Council (AU), Western Sydney University (AU), The University of Notre Dame Australia (AU), Macquarie University (AU)
Openalex Percentile: Top 34%
Colorectal Cancer Surgical Treatments
0.28
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.